Delivery Order SPE2DE24D0013-SPE2D625F1CA5
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $2,471.70 by the Defense Department's Medical Supply Chain organization on July 18, 2025, with an ultimate completion date of August 1, 2025. This firm fixed-price delivery order carries no set-aside designation and represents procurement of diagnostic equipment, reagents, or testing services from Cepheid's core product portfolio, which includes GeneXpert...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $27,235.80 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, designated XPRSMVP-10, was issued on June 4, 2025, with an ultimate completion date of June 11, 2025. The award carries no set-aside designation and represents a continuation of the government's procurement of diagnostic testing solutions from Cepheid, a company...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, received a $6,800 firm fixed-price delivery order (XPRS4PLEX-10) from the Defense Department's Medical Supply Chain on August 22, 2025, with an ultimate completion date of August 29, 2025. This delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of molecular diagnostic technologies and test kits to federal defense and healthcare systems. This...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on June 16, 2025, with an ultimate completion date of June 24, 2025. Cepheid, a for-profit manufacturer of molecular diagnostic solutions headquartered in Sunnyvale, California, specializes in advanced diagnostic systems and test kits for infectious diseases and clinical testing. The contract carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility....
- The U.S. Defense Department's Medical Supply Chain division awarded a $95,200 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with final completion scheduled for September 5, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in GeneXpert diagnostic systems and associated...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,361.79 to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. This firm fixed-price delivery order, issued on August 20, 2025, with an ultimate completion date of August 27, 2025, represents work to be performed at Cepheid's Sunnyvale facility. The contract carries no set-aside designation and is identified as delivery order XPRSMVP-10 under contract number...
- The U.S. Defense Medical Supply Chain awarded a $1,854 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The award is associated with Cepheid's broader federal contracting portfolio, which includes two significant Indefinite...
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,024 firm fixed-price delivery order to Cepheid Inc. on August 7, 2025, with an ultimate completion date of August 14, 2025. The delivery order, designated XPRSTREPA-10, was issued without a set-aside designation to the Sunnyvale, California-based molecular diagnostics manufacturer. This delivery order represents a continuation of Cepheid's longstanding federal contract relationship, drawing from the company's existing...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1CA5Delivery Order
The U.S. Defense Department's Medical Supply Chain awarded a $27,235.80 firm fixed-price delivery order to Cepheid Inc. on June 6, 2025, with an ultimate completion date of June 13, 2025. This delivery order, issued under contract number XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions, specializing in advanced GeneXpert diagnostic systems and associated test kits for detecting infectious diseases and clinical conditions across federal healthcare systems. This delivery order is part of Cepheid's broader engagement with federal defense health agencies, leveraging the company's established expertise in molecular diagnostics. Cepheid maintains significant indefinite delivery vehicles with the Department of Veterans Affairs, including a $32.8 million contract with VA's Veterans Integrated Service Network 6 for molecular diagnostic testing reagents and assays through 2030, and a $2.5 million contract with Veterans Integrated Service Network 21 for PCR testing services. The company's federal portfolio focuses on diagnostic solutions for high-impact infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other critical laboratory microbiology applications essential to military and veteran healthcare delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.2k | 6/6/25 |